Filing Details
- Accession Number:
- 0000950170-23-046432
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-05 16:36:40
- Reporting Period:
- 2023-08-31
- Accepted Time:
- 2023-09-05 16:36:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1756262 | Transmedics Group Inc. | TMDX | Electromedical & Electrotherapeutic Apparatus (3845) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1773663 | Miriam Provost | C/O Transmedics Group, Inc. 200 Minuteman Road Andover MA 01810 | Vp, Global Regulatory Affairs | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-08-31 | 1,785 | $3.22 | 22,624 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2023-08-31 | 3,695 | $38.46 | 26,319 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-08-31 | 2,708 | $66.52 | 23,611 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2023-08-31 | 1,785 | $0.00 | 1,785 | $3.22 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2023-08-31 | 3,695 | $0.00 | 3,695 | $38.46 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
16,496 | 2028-04-05 | No | 4 | M | Direct | |
11,410 | 2031-02-24 | No | 4 | M | Direct |
Footnotes
- The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options.
- The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $66.40 to $66.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- Includes 5,685 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- The option is fully vested.
- The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.